(Q38003369)

26 August 2017

title

Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections (English)

1 reference

26 August 2017

author name string

Pablo S Corona Pérez-Cardona

1

1 reference

26 August 2017

Victor Barro Ojeda

2

1 reference

26 August 2017

Dolors Rodriguez Pardo

3

1 reference

26 August 2017

Carlos Pigrau Serrallach

4

1 reference

26 August 2017

Ernesto Guerra Farfán

5

1 reference

26 August 2017

Carles Amat Mateu

6

1 reference

26 August 2017

Xavier Flores Sanchez

7

1 reference

26 August 2017

language of work or name

English

0 references

publication date

17 April 2012

1 reference

Journal of Antimicrobial Chemotherapy

26 August 2017

published in

1 reference

26 August 2017

volume

67

1 reference

26 August 2017

issue

7

1 reference

26 August 2017

page(s)

1749-1754

1 reference

Prosthetic-joint infections

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Prosthetic joint infection: recent developments in diagnosis and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Daptomycin in bone and joint infections: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Limited success with open debridement and retention of components in the treatment of acute staphylococcus aureus infections after total knee arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Rhabdomyolysis and acute renal failure in a patient treated with daptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS119

21 January 2018

Identifiers

DOI

10.1093/JAC/DKS119

1 reference

26 August 2017

1 reference